VYNE Therapeutics (VYNE) Misses Q1 EPS by 20c

VYNE Therapeutics (NASDAQ: VYNE) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $200 thousand.

For earnings history and earnings-related data on VYNE Therapeutics (VYNE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Software M&A heats up: Which SaaS stocks could be next for private equity?